The term "portable diagnostic device" (or PDD for
short) refers to a wide range of medical devices that are either made for
external use (that can be used in the field) or for internal use in the
doctor's office. They are designed to be used quickly and easily by any patient
and also provides continuous and non-invasive monitoring of health parameters.
Moreover, they also provide real-time information to a healthcare provider
through connectivity.
Growing advancement in the field of medical device such as smart
wearable’s and image-guided therapy systems is predominantly fueling the growth
of the portable diagnostic device market. For instance, in January 2019, Royal Philips announced
Azurion with FlexArm, to set a new standard for patient imaging and positioning
flexibility for image-guided procedures. Rising awareness regarding the
advantage of portable medical devices is again anticipated to foster market
growth. Increasing manufacturer's focus on the development of compact,
wireless, and user-friendly is again projected to foster the growth of the
portable diagnostic device market. Growing advancement in the field of embedded
systems, sensors, and electronics is contributing to market growth over the
forecast period. Also, the growing geriatric population is increasing the
prevalence of chronic diseases such as diabetes and cancer which is again
driving demand for portable diagnostic devices.
From the geographical point of view, North America is
expected to exhibit significant growth over the forecast period and this is
attributed to continuous approval of the innovative products by the U.S. Food
and Drug Administration (FDA) in the region. For instance, in September 2019,
Little Sparrows Technologies, a neonatal medical device startup committed to
promoting the well-being of newborns, announced it has received 510(k)
clearance from the Food and Drug Administration (FDA) for the bili-hut™. The bili-hut
is an innovative ultraportable neonatal phototherapy system that leverages a
bassinet-like design to treat hyperbilirubinemia, commonly known as neonatal
jaundice.
Key Developments:
1. In April 2020, Mindray Medical a global provider of medical
devices and solutions, announces the launch of the new portable ultrasound
systems, ME series to enhance clinical confidence during critical and emergency
COVID-19 cases. They are now available in Europe and other selected countries.
2. In March 2020, Royal Philips a global health technology
provider announced that it has increased the production of certain critical
care products and solutions to help diagnose and treat patients with the new
coronavirus disease (COVID-19).
No comments:
Post a Comment